What is EFC Pharma?
EFC Pharma operates as a comprehensive provider of pharmaceutical development and commercialization services. The company's expertise spans drug development, formulation, regulatory affairs, and commercialization strategies. EFC Pharma collaborates with a broad spectrum of clients, ranging from emerging enterprises to established Fortune 100 corporations, facilitating the delivery of FDA-approved branded and generic pharmaceutical products. Their deep industry knowledge and established network enable them to guide clients through the entire product lifecycle, from initial discovery to market maturity, ensuring efficient manufacturing and regulatory compliance to maximize client ROI.
How much funding has EFC Pharma raised?
EFC Pharma has raised a total of $20K across 1 funding round:
Debt
$20K
Debt (2021): $20K with participation from PPP
What's next for EFC Pharma?
With substantial expansion capital, EFC Pharma is poised to accelerate its strategic initiatives. This latest investment is expected to fuel further development of its service offerings, enhance operational capacity, and potentially expand its client base into new therapeutic areas or geographical markets. The company's focus on end-to-end pharmaceutical solutions suggests a strategic direction aimed at solidifying its position as a key partner for drug developers seeking efficient and compliant pathways to market.
See full EFC Pharma company page
